-
1
-
-
0023270567
-
A new member of the immunoglobulin superfamily-CTLA-4
-
Brunet J.F., Denizot F., Luciani M.F., Roux-Dosseto M., Suzan M., Mattei M.G., et al. A new member of the immunoglobulin superfamily-CTLA-4. Nature 1987, 328:267-270.
-
(1987)
Nature
, vol.328
, pp. 267-270
-
-
Brunet, J.F.1
Denizot, F.2
Luciani, M.F.3
Roux-Dosseto, M.4
Suzan, M.5
Mattei, M.G.6
-
2
-
-
0026486220
-
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes
-
Linsley P.S., Greene J.L., Tan P., Bradshaw J., Ledbetter J.A., Anasetti C., et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med 1992, 176:1595-1604.
-
(1992)
J Exp Med
, vol.176
, pp. 1595-1604
-
-
Linsley, P.S.1
Greene, J.L.2
Tan, P.3
Bradshaw, J.4
Ledbetter, J.A.5
Anasetti, C.6
-
3
-
-
0024205313
-
Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains
-
Dariavach P., Mattei M.G., Golstein P., Lefranc M.P. Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol 1988, 18:1901-1905.
-
(1988)
Eur J Immunol
, vol.18
, pp. 1901-1905
-
-
Dariavach, P.1
Mattei, M.G.2
Golstein, P.3
Lefranc, M.P.4
-
4
-
-
0034658408
-
Structural analysis of CTLA-4 function in vivo
-
Masteller E.L., Chuang E., Mullen A.C., Reiner S.L., Thompson C.B. Structural analysis of CTLA-4 function in vivo. J Immunol 2000, 164:5319-5327.
-
(2000)
J Immunol
, vol.164
, pp. 5319-5327
-
-
Masteller, E.L.1
Chuang, E.2
Mullen, A.C.3
Reiner, S.L.4
Thompson, C.B.5
-
5
-
-
0025735829
-
CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location
-
Harper K., Balzano C., Rouvier E., Mattei M.G., Luciani M.F., Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991, 147:1037-1044.
-
(1991)
J Immunol
, vol.147
, pp. 1037-1044
-
-
Harper, K.1
Balzano, C.2
Rouvier, E.3
Mattei, M.G.4
Luciani, M.F.5
Golstein, P.6
-
6
-
-
77957099358
-
Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation
-
Yokosuka T., Kobayashi W., Takamatsu M., Sakata-Sogawa K., Zeng H., Hashimoto-Tane A., et al. Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation. Immunity 2010, 33:326-339.
-
(2010)
Immunity
, vol.33
, pp. 326-339
-
-
Yokosuka, T.1
Kobayashi, W.2
Takamatsu, M.3
Sakata-Sogawa, K.4
Zeng, H.5
Hashimoto-Tane, A.6
-
7
-
-
0028484545
-
CTLA-4 can function as a negative regulator of T cell activation
-
Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994, 1:405-413.
-
(1994)
Immunity
, vol.1
, pp. 405-413
-
-
Walunas, T.L.1
Lenschow, D.J.2
Bakker, C.Y.3
Linsley, P.S.4
Freeman, G.J.5
Green, J.M.6
-
8
-
-
0036569236
-
CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases
-
Guntermann C., Alexander D.R. CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases. J Immunol 2002, 168:4420-4429.
-
(2002)
J Immunol
, vol.168
, pp. 4420-4429
-
-
Guntermann, C.1
Alexander, D.R.2
-
9
-
-
0029899783
-
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells
-
Krummel M.F., Allison J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 1996, 183:2533-2540.
-
(1996)
J Exp Med
, vol.183
, pp. 2533-2540
-
-
Krummel, M.F.1
Allison, J.P.2
-
10
-
-
0028867420
-
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
-
Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995, 3:541-547.
-
(1995)
Immunity
, vol.3
, pp. 541-547
-
-
Tivol, E.A.1
Borriello, F.2
Schweitzer, A.N.3
Lynch, W.P.4
Bluestone, J.A.5
Sharpe, A.H.6
-
11
-
-
0028791059
-
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
-
Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995, 270:985-988.
-
(1995)
Science
, vol.270
, pp. 985-988
-
-
Waterhouse, P.1
Penninger, J.M.2
Timms, E.3
Wakeham, A.4
Shahinian, A.5
Lee, K.P.6
-
12
-
-
0344299189
-
Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous
-
Bachmann M.F., Kohler G., Ecabert B., Mak T.W., Kopf M. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J Immunol 1999, 163:1128-1131.
-
(1999)
J Immunol
, vol.163
, pp. 1128-1131
-
-
Bachmann, M.F.1
Kohler, G.2
Ecabert, B.3
Mak, T.W.4
Kopf, M.5
-
13
-
-
75649095238
-
CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms
-
Ise W., Kohyama M., Nutsch K.M., Lee H.M., Suri A., Unanue E.R., et al. CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nat Immunol 2010, 11:129-135.
-
(2010)
Nat Immunol
, vol.11
, pp. 129-135
-
-
Ise, W.1
Kohyama, M.2
Nutsch, K.M.3
Lee, H.M.4
Suri, A.5
Unanue, E.R.6
-
14
-
-
53749094183
-
CTLA-4 control over Foxp3+ regulatory T cell function
-
Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T., Miyara M., Fehervari Z., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008, 322:271-275.
-
(2008)
Science
, vol.322
, pp. 271-275
-
-
Wing, K.1
Onishi, Y.2
Prieto-Martin, P.3
Yamaguchi, T.4
Miyara, M.5
Fehervari, Z.6
-
15
-
-
76549084610
-
Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity
-
Jain N., Nguyen H., Chambers C., Kang J. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Proc Natl Acad Sci U S A 2010, 107:1524-1528.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 1524-1528
-
-
Jain, N.1
Nguyen, H.2
Chambers, C.3
Kang, J.4
-
16
-
-
33749038866
-
Reversal of the TCR stop signal by CTLA-4
-
Schneider H., Downey J., Smith A., Zinselmeyer B.H., Rush C., Brewer J.M., et al. Reversal of the TCR stop signal by CTLA-4. Science 2006, 313:1972-1975.
-
(2006)
Science
, vol.313
, pp. 1972-1975
-
-
Schneider, H.1
Downey, J.2
Smith, A.3
Zinselmeyer, B.H.4
Rush, C.5
Brewer, J.M.6
-
17
-
-
0034679560
-
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
-
Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N., et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000, 192:303-310.
-
(2000)
J Exp Med
, vol.192
, pp. 303-310
-
-
Takahashi, T.1
Tagami, T.2
Yamazaki, S.3
Uede, T.4
Shimizu, J.5
Sakaguchi, N.6
-
18
-
-
21244437086
-
B7-independent inhibition of T cells by CTLA-4
-
Chikuma S., Abbas A.K., Bluestone J.A. B7-independent inhibition of T cells by CTLA-4. J Immunol 2005, 175:177-181.
-
(2005)
J Immunol
, vol.175
, pp. 177-181
-
-
Chikuma, S.1
Abbas, A.K.2
Bluestone, J.A.3
-
19
-
-
0035803552
-
Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function
-
Martin M., Schneider H., Azouz A., Rudd C.E. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J Exp Med 2001, 194:1675-1681.
-
(2001)
J Exp Med
, vol.194
, pp. 1675-1681
-
-
Martin, M.1
Schneider, H.2
Azouz, A.3
Rudd, C.E.4
-
20
-
-
0037141091
-
Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation
-
Darlington P.J., Baroja M.L., Chau T.A., Siu E., Ling V., Carreno B.M., et al. Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation. J Exp Med 2002, 195:1337-1347.
-
(2002)
J Exp Med
, vol.195
, pp. 1337-1347
-
-
Darlington, P.J.1
Baroja, M.L.2
Chau, T.A.3
Siu, E.4
Ling, V.5
Carreno, B.M.6
-
21
-
-
0037244012
-
Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4
-
Chikuma S., Imboden J.B., Bluestone J.A. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2003, 197:129-135.
-
(2003)
J Exp Med
, vol.197
, pp. 129-135
-
-
Chikuma, S.1
Imboden, J.B.2
Bluestone, J.A.3
-
22
-
-
84861880306
-
Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells
-
Tai X., Van Laethem F., Pobezinsky L., Guinter T., Sharrow S.O., Adams A., et al. Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood 2012, 119:5155-5163.
-
(2012)
Blood
, vol.119
, pp. 5155-5163
-
-
Tai, X.1
Van Laethem, F.2
Pobezinsky, L.3
Guinter, T.4
Sharrow, S.O.5
Adams, A.6
-
23
-
-
84858590457
-
Constitutive clathrin-mediated endocytosis of CTLA-4 persists during T cell activation
-
Qureshi O.S., Kaur S., Hou T.Z., Jeffery L.E., Poulter N.S., Briggs Z., et al. Constitutive clathrin-mediated endocytosis of CTLA-4 persists during T cell activation. J Biol Chem 2012, 287:9429-9440.
-
(2012)
J Biol Chem
, vol.287
, pp. 9429-9440
-
-
Qureshi, O.S.1
Kaur, S.2
Hou, T.Z.3
Jeffery, L.E.4
Poulter, N.S.5
Briggs, Z.6
-
24
-
-
0033567050
-
Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2
-
Schneider H., Martin M., Agarraberes F.A., Yin L., Rapoport I., Kirchhausen T., et al. Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. J Immunol 1999, 163:1868-1879.
-
(1999)
J Immunol
, vol.163
, pp. 1868-1879
-
-
Schneider, H.1
Martin, M.2
Agarraberes, F.A.3
Yin, L.4
Rapoport, I.5
Kirchhausen, T.6
-
25
-
-
0032545452
-
Molecular basis of T cell inactivation by CTLA-4
-
Lee K.M., Chuang E., Griffin M., Khattri R., Hong D.K., Zhang W., et al. Molecular basis of T cell inactivation by CTLA-4. Science 1998, 282:2263-2266.
-
(1998)
Science
, vol.282
, pp. 2263-2266
-
-
Lee, K.M.1
Chuang, E.2
Griffin, M.3
Khattri, R.4
Hong, D.K.5
Zhang, W.6
-
26
-
-
84876946146
-
PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cells
-
Smida M., Cammann C., Gurbiel S., Kerstin N., Lingel H., Lindquist S., et al. PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cells. Cell Commun Signal 2013, 11:28.
-
(2013)
Cell Commun Signal
, vol.11
, pp. 28
-
-
Smida, M.1
Cammann, C.2
Gurbiel, S.3
Kerstin, N.4
Lingel, H.5
Lindquist, S.6
-
27
-
-
77952544480
-
CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase Itch
-
Hoff H., Kolar P., Ambach A., Radbruch A., Brunner-Weinzierl M.C. CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase Itch. Mol Immunol 2010, 47:1875-1881.
-
(2010)
Mol Immunol
, vol.47
, pp. 1875-1881
-
-
Hoff, H.1
Kolar, P.2
Ambach, A.3
Radbruch, A.4
Brunner-Weinzierl, M.C.5
-
28
-
-
66049098149
-
Structure-Function analysis of the CTLA-4 interaction with PP2A
-
Teft W.A., Chau T.A., Madrenas J. Structure-Function analysis of the CTLA-4 interaction with PP2A. BMC Immunol 2009, 10:23.
-
(2009)
BMC Immunol
, vol.10
, pp. 23
-
-
Teft, W.A.1
Chau, T.A.2
Madrenas, J.3
-
29
-
-
84861724649
-
Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells
-
Kessel A., Haj T., Peri R., Snir A., Melamed D., Sabo E., et al. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun Rev 2012, 11:670-677.
-
(2012)
Autoimmun Rev
, vol.11
, pp. 670-677
-
-
Kessel, A.1
Haj, T.2
Peri, R.3
Snir, A.4
Melamed, D.5
Sabo, E.6
-
30
-
-
26244448037
-
CD4+ regulatory T cells: mechanisms of induction and effector function
-
Bacchetta R., Gregori S., Roncarolo M.G. CD4+ regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev 2005, 4:491-496.
-
(2005)
Autoimmun Rev
, vol.4
, pp. 491-496
-
-
Bacchetta, R.1
Gregori, S.2
Roncarolo, M.G.3
-
31
-
-
59849085140
-
Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity
-
Schmidt E.M., Wang C.J., Ryan G.A., Clough L.E., Qureshi O.S., Goodall M., et al. Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity. J Immunol 2009, 182:274-282.
-
(2009)
J Immunol
, vol.182
, pp. 274-282
-
-
Schmidt, E.M.1
Wang, C.J.2
Ryan, G.A.3
Clough, L.E.4
Qureshi, O.S.5
Goodall, M.6
-
32
-
-
79955529454
-
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
-
Qureshi O.S., Zheng Y., Nakamura K., Attridge K., Manzotti C., Schmidt E.M., et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 2011, 332:600-603.
-
(2011)
Science
, vol.332
, pp. 600-603
-
-
Qureshi, O.S.1
Zheng, Y.2
Nakamura, K.3
Attridge, K.4
Manzotti, C.5
Schmidt, E.M.6
-
33
-
-
84872572798
-
CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire
-
Verhagen J., Genolet R., Britton G.J., Stevenson B.J., Sabatos-Peyton C.A., Dyson J., et al. CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire. Proc Natl Acad Sci U S A 2013, 110:E221-E230.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
-
-
Verhagen, J.1
Genolet, R.2
Britton, G.J.3
Stevenson, B.J.4
Sabatos-Peyton, C.A.5
Dyson, J.6
-
34
-
-
62549084354
-
Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease
-
Verhagen J., Gabrysova L., Minaee S., Sabatos C.A., Anderson G., Sharpe A.H., et al. Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease. Proc Natl Acad Sci U S A 2009, 106:3306-3311.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 3306-3311
-
-
Verhagen, J.1
Gabrysova, L.2
Minaee, S.3
Sabatos, C.A.4
Anderson, G.5
Sharpe, A.H.6
-
35
-
-
84867379035
-
Coinhibitory molecules in autoimmune diseases
-
Watanabe N., Nakajima H. Coinhibitory molecules in autoimmune diseases. Clin Dev Immunol 2012, 2012:269756.
-
(2012)
Clin Dev Immunol
, vol.2012
, pp. 269756
-
-
Watanabe, N.1
Nakajima, H.2
-
36
-
-
84857037947
-
The genomics of autoimmune disease in the era of genome-wide association studies and beyond
-
Lessard C.J., Ice J.A., Adrianto I., Wiley G.B., Kelly J.A., Gaffney P.M., et al. The genomics of autoimmune disease in the era of genome-wide association studies and beyond. Autoimmun Rev 2012, 11:267-275.
-
(2012)
Autoimmun Rev
, vol.11
, pp. 267-275
-
-
Lessard, C.J.1
Ice, J.A.2
Adrianto, I.3
Wiley, G.B.4
Kelly, J.A.5
Gaffney, P.M.6
-
37
-
-
80054115387
-
CTLA4 gene variants in autoimmunity and cancer: a comparative review
-
Ghaderi A. CTLA4 gene variants in autoimmunity and cancer: a comparative review. Iran J Immunol 2011, 8:127-149.
-
(2011)
Iran J Immunol
, vol.8
, pp. 127-149
-
-
Ghaderi, A.1
-
38
-
-
84872440812
-
CTLA-4-1722T/C polymorphism and systemic lupus erythematosus susceptibility: a meta-analysis involving ten separate studies
-
Zhu J.M., Li B.K., Chen G.M., Feng C.C., Cen H., Fan Y.G., et al. CTLA-4-1722T/C polymorphism and systemic lupus erythematosus susceptibility: a meta-analysis involving ten separate studies. Immunol Invest 2013, 42:91-105.
-
(2013)
Immunol Invest
, vol.42
, pp. 91-105
-
-
Zhu, J.M.1
Li, B.K.2
Chen, G.M.3
Feng, C.C.4
Cen, H.5
Fan, Y.G.6
-
39
-
-
75149151978
-
Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus
-
Jury E.C., Flores-Borja F., Kalsi H.S., Lazarus M., Isenberg D.A., Mauri C., et al. Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus. Eur J Immunol 2010, 40:569-578.
-
(2010)
Eur J Immunol
, vol.40
, pp. 569-578
-
-
Jury, E.C.1
Flores-Borja, F.2
Kalsi, H.S.3
Lazarus, M.4
Isenberg, D.A.5
Mauri, C.6
-
40
-
-
31944448797
-
The soluble CTLA-4 receptor: a new marker in autoimmune diseases
-
Pawlak E., Kochanowska I.E., Frydecka I., Kielbinski M., Potoczek S., Bilinska M. The soluble CTLA-4 receptor: a new marker in autoimmune diseases. Arch Immunol Ther Exp (Warsz) 2005, 53:336-341.
-
(2005)
Arch Immunol Ther Exp (Warsz)
, vol.53
, pp. 336-341
-
-
Pawlak, E.1
Kochanowska, I.E.2
Frydecka, I.3
Kielbinski, M.4
Potoczek, S.5
Bilinska, M.6
-
41
-
-
77957682858
-
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial
-
Merrill J.T., Burgos-Vargas R., Westhovens R., Chalmers A., D'Cruz D., Wallace D.J., et al. The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010, 62:3077-3087.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 3077-3087
-
-
Merrill, J.T.1
Burgos-Vargas, R.2
Westhovens, R.3
Chalmers, A.4
D'Cruz, D.5
Wallace, D.J.6
-
42
-
-
84869479561
-
Abatacept for systemic lupus erythematosus: the outlook
-
Mok C.C. Abatacept for systemic lupus erythematosus: the outlook. Expert Opin Biol Ther 2012, 12:1559-1561.
-
(2012)
Expert Opin Biol Ther
, vol.12
, pp. 1559-1561
-
-
Mok, C.C.1
-
43
-
-
36148944492
-
B cells in SLE: different biological drugs for different pathogenic mechanisms
-
Diamanti A.P., Rosado M.M., Carsetti R., Valesini G. B cells in SLE: different biological drugs for different pathogenic mechanisms. Autoimmun Rev 2007, 7:143-148.
-
(2007)
Autoimmun Rev
, vol.7
, pp. 143-148
-
-
Diamanti, A.P.1
Rosado, M.M.2
Carsetti, R.3
Valesini, G.4
-
44
-
-
84885475482
-
Abatacept as a first-line biological therapy
-
Caporali R., Bugatti S., Cavagna L., Antivalle M., Atzeni F., Puttini P.S. Abatacept as a first-line biological therapy. Autoimmun Rev Jun 24 2013, http://dx.doi.org/1568-9972(13)00114-6.
-
(2013)
Autoimmun Rev
-
-
Caporali, R.1
Bugatti, S.2
Cavagna, L.3
Antivalle, M.4
Atzeni, F.5
Puttini, P.S.6
-
45
-
-
84886946889
-
Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: could it be the first step of the treatment?
-
Caporali R., Bugatti S., Cavagna L., Antivalle M., Sarzi-Puttini P. Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: could it be the first step of the treatment?. Autoimmun Rev Jun 15 2013, http://dx.doi.org/S1568-9972(13)00109-2.
-
(2013)
Autoimmun Rev
-
-
Caporali, R.1
Bugatti, S.2
Cavagna, L.3
Antivalle, M.4
Sarzi-Puttini, P.5
-
46
-
-
84877819591
-
Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis
-
Cutolo M., Nadler S.G. Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis. Autoimmun Rev 2013, 12:758-767.
-
(2013)
Autoimmun Rev
, vol.12
, pp. 758-767
-
-
Cutolo, M.1
Nadler, S.G.2
-
47
-
-
54549119268
-
Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept
-
Fiocco U., Sfriso P., Oliviero F., Pagnin E., Scagliori E., Campana C., et al. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept. Autoimmun Rev 2008, 8:76-82.
-
(2008)
Autoimmun Rev
, vol.8
, pp. 76-82
-
-
Fiocco, U.1
Sfriso, P.2
Oliviero, F.3
Pagnin, E.4
Scagliori, E.5
Campana, C.6
-
48
-
-
84884699849
-
Long-term safety of abatacept in patients with rheumatoid arthritis
-
Atzeni F., Puttini P.S., Mutti A., Bugatti S., Cavagna L., Caporali R. Long-term safety of abatacept in patients with rheumatoid arthritis. Autoimmun Rev Jun 22 2013, http://dx.doi.org/S1568-9972(13)00115-8.
-
(2013)
Autoimmun Rev
-
-
Atzeni, F.1
Puttini, P.S.2
Mutti, A.3
Bugatti, S.4
Cavagna, L.5
Caporali, R.6
-
49
-
-
84876959366
-
Novel therapeutic agents in clinical development for systemic lupus erythematosus
-
Jordan N., Lutalo P.M., D'Cruz D.P. Novel therapeutic agents in clinical development for systemic lupus erythematosus. BMC Med 2013, 11:120.
-
(2013)
BMC Med
, vol.11
, pp. 120
-
-
Jordan, N.1
Lutalo, P.M.2
D'Cruz, D.P.3
-
50
-
-
84868126198
-
Abatacept for lupus nephritis: alternative definitions of complete response support conflicting conclusions
-
Wofsy D., Hillson J.L., Diamond B. Abatacept for lupus nephritis: alternative definitions of complete response support conflicting conclusions. Arthritis Rheum 2012, 64:3660-3665.
-
(2012)
Arthritis Rheum
, vol.64
, pp. 3660-3665
-
-
Wofsy, D.1
Hillson, J.L.2
Diamond, B.3
-
51
-
-
84874340211
-
CTLA-4 polymorphisms and systemic lupus erythematosus: a comprehensive meta-analysis
-
Liu J., Zhang H.X. CTLA-4 polymorphisms and systemic lupus erythematosus: a comprehensive meta-analysis. Genet Test Mol Biomarkers 2013, 17:226-231.
-
(2013)
Genet Test Mol Biomarkers
, vol.17
, pp. 226-231
-
-
Liu, J.1
Zhang, H.X.2
-
52
-
-
84873705531
-
1722T/C polymorphism (rs733618) of CTLA-4 significantly associated with systemic lupus erythematosus (SLE): a comprehensive meta-analysis
-
Liu J., Zhang H. 1722T/C polymorphism (rs733618) of CTLA-4 significantly associated with systemic lupus erythematosus (SLE): a comprehensive meta-analysis. Hum Immunol 2013, 74:341-347.
-
(2013)
Hum Immunol
, vol.74
, pp. 341-347
-
-
Liu, J.1
Zhang, H.2
-
53
-
-
17144378972
-
CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis
-
Lee Y.H., Harley J.B., Nath S.K. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum Genet 2005, 116:361-367.
-
(2005)
Hum Genet
, vol.116
, pp. 361-367
-
-
Lee, Y.H.1
Harley, J.B.2
Nath, S.K.3
-
54
-
-
84876818789
-
CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China
-
Liu C.P., Jiang J.A., Wang T., Liu X.M., Gao L., Zhu R.R., et al. CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China. Genet Mol Res 2013, 12:1373-1382.
-
(2013)
Genet Mol Res
, vol.12
, pp. 1373-1382
-
-
Liu, C.P.1
Jiang, J.A.2
Wang, T.3
Liu, X.M.4
Gao, L.5
Zhu, R.R.6
-
55
-
-
84863750045
-
Association between the CTLA-4+49 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis
-
Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. Association between the CTLA-4+49 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep 2012, 39:5599-5605.
-
(2012)
Mol Biol Rep
, vol.39
, pp. 5599-5605
-
-
Lee, Y.H.1
Bae, S.C.2
Choi, S.J.3
Ji, J.D.4
Song, G.G.5
-
56
-
-
84863930632
-
Association between the CTLA-4+49A/G polymorphism and Graves' disease: a meta-analysis
-
Si X., Zhang X., Tang W., Luo Y. Association between the CTLA-4+49A/G polymorphism and Graves' disease: a meta-analysis. Exp Ther Med 2012, 4:538-544.
-
(2012)
Exp Ther Med
, vol.4
, pp. 538-544
-
-
Si, X.1
Zhang, X.2
Tang, W.3
Luo, Y.4
-
57
-
-
84876282109
-
The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves' disease in the Chinese population
-
Du L., Yang J., Huang J., Ma Y., Wang H., Xiong T., et al. The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves' disease in the Chinese population. BMC Med Genet 2013, 14:46.
-
(2013)
BMC Med Genet
, vol.14
, pp. 46
-
-
Du, L.1
Yang, J.2
Huang, J.3
Ma, Y.4
Wang, H.5
Xiong, T.6
-
58
-
-
84868007779
-
Association between the CTLA-4+49A/G polymorphism and type 1 diabetes: a meta-analysis
-
Si X., Zhang X., Luo Y., Tang W. Association between the CTLA-4+49A/G polymorphism and type 1 diabetes: a meta-analysis. Genet Test Mol Biomarkers 2012, 16:1336-1342.
-
(2012)
Genet Test Mol Biomarkers
, vol.16
, pp. 1336-1342
-
-
Si, X.1
Zhang, X.2
Luo, Y.3
Tang, W.4
|